May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 22, 2025

FDA Approves Mepolizumab for Eosinophilic COPD

Nucala gains FDA approval to treat chronic obstructive pulmonary disease, expanding its use to patients with eosinophilic inflammation.

Conexiant

May 20, 2025

ICU Sedation Economics: A $1 Difference

Study finds dexmedetomidine, clonidine, and propofol have comparable cost-effectiveness for critically ill patients on mechanical ventilation.

Conexiant

May 19, 2025

Protein-Based COVID Vaccine Gains FDA Approval

The FDA has approved the first recombinant protein-based, non-mRNA COVID-19 vaccine.

Conexiant

May 19, 2025

Could New COPD Criteria Double Diagnosis Rates?

Multidimensional schema incorporating CT imaging and symptoms identifies high-risk patients without traditional airflow obstruction.

Conexiant

May 14, 2025

Home Wash Leaves Scrubs Full of Superbugs

Home washing machines often fail to disinfect health care workers' uniforms, leaving antibiotic-resistant bacteria behind.

Conexiant

May 09, 2025

Mediastinitis Carries Highest Death Risk Postsurgery

Mediastinitis leads to the highest risk of death within 90 days after surgery.

Conexiant

May 07, 2025

Corticosteroid Use Linked to Weight, Waist Gains

In a study of over 80,000 adults, long-term corticosteroid use—including inhaled and topical forms—was associated with gradual weight gain and waist enlargement, especially in women and those with overweight or obesity.

Conexiant

April 30, 2025

New Phase III Data on Brensocatib Therapy

Phase III trial results show that once-daily brensocatib reduces pulmonary exacerbations and slows lung function decline in patients with bronchiectasis.

Conexiant